Andre Walker, Senior VP, Research&Development at NEVRO CORP (NVRO), sold 8,000 shares at $57.00 ($476K) on 2015-11-30, disclosed to the SEC on 2015-12-02.
Scheduled sale ($476k) by Senior VP, Research&Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.00 | 1,000 | $56K | 11.8% |
| 2 | $57.00 | 1,000 | $57K | 12.0% |
| 3 | $58.00 | 1,000 | $58K | 12.2% |
| 4 | $59.00 | 1,000 | $59K | 12.4% |
| 5 | $60.00 | 1,000 | $60K | 12.6% |
| 6 | $61.00 | 1,000 |
| $61K |
| 12.8% |
| 7 | $62.00 | 1,000 | $62K | 13.0% |
| 8 | $63.00 | 1,000 | $63K | 13.2% |
| Total | $59.50 avg | 8,000 | $476K | 100% |
| Filing → |
| NVRO | SELL | 2016-01-13 | $565K | — | Filing → |
| NVRO | SELL | 2015-12-18 | $897 | — | Filing → |
| NVRO | SELL | 2015-12-16 | $201K | — | Filing → |